Shekeeb Mohammad
Overview
Explore the profile of Shekeeb Mohammad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dale R, Mohammad S, Han V, Nishida H, Goel H, Tangye S, et al.
Dev Med Child Neurol
. 2025 Feb;
PMID: 39985218
We report eight children with de novo pathogenic DNA variants in chromatin-related genes: MORC2, CHD7, KANSL1, KMT2D, ZMYND11, HIST1HIE, EP300, and KMT2B. All children experienced infection or vaccine-provoked neuroregression or...
2.
DSilva A, Barnes J, Djafar J, Bhattacharya K, Yan J, Mohammad S, et al.
Neurotherapeutics
. 2025 Feb;
22(2):e00546.
PMID: 39948021
Childhood dementias, a group of neurological disorders are characterised by neurocognitive decline, with physical and psychosocial impacts for individuals. With therapy available for <5 % of childhood dementias, there is...
3.
Djafar J, Nevin S, Smith N, Ardern-Holmes S, Bhattacharya K, Dale R, et al.
Arch Dis Child
. 2025 Jan;
PMID: 39832815
Objective: To explore quality of life outcomes for caregivers of children with childhood dementia including the positive and negative impact of caregiving. The secondary aim was to explore caregivers' perspectives...
4.
Meagher C, Kariyawasam D, Concepcion K, Dale R, Hetherington K, Mohammad S, et al.
Arch Dis Child
. 2024 Nov;
PMID: 39521449
Objective: Parents and caregivers of children with neurological conditions express interest in new and developing treatments and trials; however, they have limited knowledge of, and access to, reliable information. This...
5.
Tsang E, Han V, Flutter C, Alshammery S, Keating B, Williams T, et al.
EBioMedicine
. 2024 May;
104:105156.
PMID: 38768529
Background: Kabuki syndrome (KS) is a genetic disorder caused by DNA mutations in KMT2D, a lysine methyltransferase that methylates histones and other proteins, and therefore modifies chromatin structure and subsequent...
6.
Nguyen C, Kariyawasam D, Ngai T, Nguyen J, Alba-Concepcion K, Grattan S, et al.
Health Expect
. 2024 May;
27(3):e14063.
PMID: 38711219
Introduction: Advanced therapies offer unprecedented opportunities for treating rare neurological disorders (RNDs) in children. However, health literacy, perceptions and understanding of novel therapies need elucidation across the RND community. This...
7.
Bosi I, Wong W, Mohammad S, Britton P, Hsu P
J Clin Immunol
. 2023 Dec;
44(1):33.
PMID: 38148399
No abstract available.
8.
Dale R, Thomas T, Patel S, Han V, Kothur K, Troedson C, et al.
Ann Clin Transl Neurol
. 2023 Jun;
10(8):1417-1432.
PMID: 37340737
Objective: Infection-triggered encephalopathy syndromes (ITES) are potentially devastating neuroinflammatory conditions. Although some ITES syndromes have recognisable MRI neuroimaging phenotypes, there are otherwise few biomarkers of disease. Early detection to enable...
9.
Wong R, Mohammad S, Parayil Sankaran B, Junek R, Kim W, Wotton T, et al.
Brain Dev
. 2023 May;
45(9):523-531.
PMID: 37156708
Background: Hyperphenylalaninemia is a biomarker for several monogenic neurotransmitter disorders where the body cannot metabolise phenylalanine to tyrosine. Biallelic pathogenic variants in DNAJC12, co-chaperone of phenylalanine, tyrosine, and tryptophan hydroxylases,...
10.
Yan J, Kothur K, Mohammad S, Chung J, Patel S, Jones H, et al.
EBioMedicine
. 2023 Apr;
91:104589.
PMID: 37119734
Background: Defining the presence of acute and chronic brain inflammation remains a challenge to clinicians due to the heterogeneity of clinical presentations and aetiologies. However, defining the presence of neuroinflammation,...